TYKOCINSKI MARK L has a total of 20 patent applications. Its first patent ever was published in 1990. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ALPINE IMMUNE SCIENCES INC, MEDIMMUNE LLC and SEEHRA JASBIR.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 3 | |
#4 | Australia | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Israel | 1 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Measuring microorganism processes | |
#6 | Analysing materials | |
#7 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Tykocinski Mark L | 19 |
#2 | Ilan Joseph | 4 |
#3 | Huang Jui-Han | 2 |
#4 | Kaplan David R | 2 |
#5 | Razmara Marjaneh | 2 |
#6 | Ido Kaminsky | 1 |
#7 | Huang Jui Han | 1 |
#8 | Michal Dranitzki Elhalel | 1 |
#9 | Mark L Tykocinski | 1 |
#10 | Noam Shani | 1 |
Publication | Filing date | Title |
---|---|---|
US2011041190A1 | Novel chimeric proteins | |
WO9612009A2 | Methods for engineering antigen-presenting cells | |
WO9425610A1 | Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule | |
WO9407366A1 | Pp14-based therapy | |
WO9320691A1 | Method for inducing tumor immunity | |
CA2050346A1 | Cd8-based pharmaceuticals |